Publication: Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study
Loading...
Program
relationships.isAuthorOf
Author
Akgun, Zuleyha
Saglam, Sezer
Yucel, Serap
Gural, Zeynep
Balik, Emre
Cipe, Gokhan
Yildiz, ŞEYMA
Okyar, Alper
Kaytan-Saglam, Esra
Advisor
Language
Type
Publisher
Journal Title
Journal ISSN
Volume Title
Abstract
The aim of this study was to evaluate efficacy and safety of chronomodulated capecitabine administered according to a specific time schedule (Brunch Regimen: Breakfast and Lunch) as a part of neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer.
Description
Source
Keywords
Keywords
Citation
Akgun Z., Saglam S., Yucel S., Gural Z., Balik E., Cipe G., Yildiz Ş., Kilickap S., Okyar A., Kaytan-Saglam E., -Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study-, CANCER CHEMOTHERAPY AND PHARMACOLOGY, cilt.74, ss.751-756, 2014